Aimmune Therapeutics | Market Exclusive

Home Tags Aimmune Therapeutics

Analyst Activity – Wedbush Reiterates Outperform on Aimmune Therapeutics (NASDAQ:AIMT)

ME Staff - March 6, 2018 0

Analyst Activity – Roth Capital Raises Its Price Target On Aimmune...

ME Staff - March 5, 2018 0

Analyst Activity – Royal Bank of Canada Raises Its Price Target...

ME Staff - February 27, 2018 0

Analyst Activity – Royal Bank of Canada Initiates Coverage On Aimmune...

ME Staff - February 7, 2018 0

Analyst Activity – Wedbush Reiterates Outperform on Aimmune Therapeutics (NASDAQ:AIMT)

ME Staff - July 24, 2017 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: Aimmune Therapeutics

Analyst Activity – Wedbush Reiterates Outperform on Aimmune Therapeutics (NASDAQ:AIMT)

Analyst Activity – Roth Capital Raises Its Price Target On Aimmune...

Analyst Activity – Royal Bank of Canada Raises Its Price Target...

Analyst Activity – Royal Bank of Canada Initiates Coverage On Aimmune...

Analyst Activity – Wedbush Reiterates Outperform on Aimmune Therapeutics (NASDAQ:AIMT)

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY